Previous close | 4,090.00 |
Open | 4,108.00 |
Bid | 3,993.00 x N/A |
Ask | 4,197.00 x N/A |
Day's range | 4,091.00 - 4,127.00 |
52-week range | 2,726.00 - 4,154.00 |
Volume | |
Avg. volume | 10,949 |
Market cap | 39.417B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 43.90 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 67.00 (2.33%) |
Ex-dividend date | 27 Mar 2023 |
1y target est | N/A |
BLANQUEFORT, France & VERNIER, Switzerland, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), today announced the signature of a definitive agreement with Givaudan, world leader in the creation of flavors and fragrances (ISIN code: CH0010645932 - Ticker: GIVN), concerning the acquisition of Naturex Iberian Partners (Givaudan's industrial site in Valencia - Spain).